Hormones: Epigenetic Contributors to Gender-Biased Autoimmunity

The Epigenetics of Autoimmune Diseases

Volumn , Issue , 2009, Pages 309-326

  Rider, Virginia ^a   Abdou, Nabih I ^b  

^a PITTSBURG STATE UNIVERSITY   (United States)

^b Center for Rheumatic Disease   (United States)

Author keywords

CAMP response element binding protein (CREB); Chromatin immunoprecipitation (ChIP) assays; Co repressors, repressing gene transcription; DNA bound transcription factors; Gender biased autoimmunity; Histone acetylation; Oestrogen and autoimmunity; Oestrogen receptors

Indexed keywords

EID: 84890153749     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470743553.ch17     Document Type: Chapter

References (108)

1. McGaha, T.L., Sorrentino, B. and Ravetch, J.V. (2005) Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science 307, 590-593.
2. Bouneaud, C., Kourilsky, P. and Bousso, P. (2000) Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13, 829-840.
3. Jacobson, D.L., Gange, S.J., Rose, N.R. and Graham, N.M. (1997) Epidemiologyand estimated population burden of selected autoimmune diseases in the Untied States. Clinical Immunology and Immunopathology 84, 223-243.
4. Privalsky, M.L. (2004) The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annual Review of Physiology 66, 315-360.
5. Khorasanizadeh, S. and Rastinejad, F. (2001) Nuclear-receptor interactions on DNA-response elements. Trends in Biochemical Sciences 26, 384-390.
6. Heldring, N., Pike, A., Andersson, S. et al. (2007) Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 37, 905-931.
7. Rider, V., Jones, S.R., Evans, M. and Abdou, N.I. (2000) Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clinical Immunology 95, 124-134.
8. Rider, V., Li, X., Peterson, G. etal. (2006) Differentialexpressionofestrogenreceptors in women with systemic lupus erythematosus. Journal of Rheumatology 33, 1093-1101.
9. Whitacre, C.C., Reingold, S.C. and O'Looney, P.A. (1999) A gender gap in autoimmunity. Science 283, 1277-1278.
10. Casoli, P., Tumiati, B. and LaSala, G. (1997) Fatal exacerbation of systemic lupus erythematosus after induction of ovulation. Journal of Rheumatology 24, 1639-1640.
11. Font, J., Pallares, L., Cervera, R. etal. (1991) Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Annals of Rheumatic Disease 50, 702-705.
12. Petri, M., Kim, M.Y., Kalunian, K.C. et al. (2005) OC-SELENA Trial, Combined oral contraceptives in women with systemic lupus erythematosus. New England Journal of Medicine 353, 2550-2558.
13. Sanchez-Guerrero, J., Uribe, A.G. and Jimenez-Santana, L. et al. (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. New England Journal of Medicine 353, 2539-2549.
14. Whitelaw, D.A. and Jessop, S.J. (2007) Major flares in women with SLE on combined oral contraception. Clinical Rheumatology 26, 2163-2165.
15. Sanchez-Guerrero, J., Liang, M.H., Karlson, E.W. et al. (1995) Post-menopausal estrogen therapy and the riskfor developing systemic lupus erythematosus. Annals of InternalMedicine 122, 430-433.
16. Rider, V., Li, X. and Abdou, N.I. (2007) Hormonalinfluences in the expression of systemic lupus erythematosus, In: Tsokos G.C., Gordon C and Smolen J.S. (eds), SystemicLupusErythematosus: a Companion to Rheumatology, pp 87-94. Mosby, Philadelphia.
17. Abdou, N.I., Rider, V., Greenwell, C. et al. (2008) Fulvestrant (Faslodex) an estrogen receptor antagonist in the therapy of females with systemic lupus erythematosus: clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial. Journal of Rheumatology 35, 797-803.
18. Rider, V., Foster, R.T., Evans, M. et al. (1998) Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. ClinicalImmunology Immunopathology 89, 171-180.
19. Rider, V., Jones, S., Evans, M. etal. (2001) Estrogen increases CD40 Ligand expression in T cells from women with systemic lupus erythematosus. Journal of Rheumatology 28, 2644-2649.
20. Straub, R.H. (2007) The complex role of estrogens in inflammation. Endocrine Reviews 28, 521-574.
21. Roubinian, J., Talal, N., Siiter, P.K. and Sadakian, J.A. (1979) Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis and Rheumatism 22, 1162-1169.
22. Grimaldi, C.M. (2006) Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Current Opinion in Rheumatology 18, 456-461.
23. Czlonkowska, A., Ciesielska, A., Gromadzka, G. et al. (2005) Estrogen and cytokines produc-tion-the possible cause of gender differences in neurological diseases. Current Pharmaceutical Design 11, 1017-1030.
24. Gourdy, P., Araujo, L.M., Zhu, R. et al. (2005) Relevance of sexual dimorphism to regulatory T cells: estrogen promotes IFN-{gamma} production by invariant natural killer T cells. Blood 105, 2415-2420.
25. Jenkins, J.K., Suwannaroj, S., Elbourne, K.B. etal. (2001) 17-ß estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A. International Immunopharmacology 1, 1897-1911.
26. Miller, L. and Hunt, J.S. (1995) Sex steroids, hormone and macrophage function. Life Sciences 59, 1-14.
27. Grimaldi, C.M., Hill, L., Xu, X. et al. (2005) Hormonal modulation of B cell development and repertoire selection. Molecular Immunology 42, 811-820.
28. Abdou, N.I., Wall, H., Lindsley, H.C. etal. (1981) The network theory in autoimmunity: in vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. Journal of Clinical Investigation 67, 1297-1304.
29. Sherer, Y., Gorstein, A., Fritzler, M.J. and Shoenfeld, Y. (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Seminars in Arthritis and Rheumatism 34, 501-537.
30. Cutolo, M., Accardo, S., Villaggio, B. et al. (1993) Presence of estrogen binding sites on macrophage like synoviocytes and CD8 + CD29 + CD45RO + T lymphocytes in normal and rheumatoid synovium. Arthritis and Rheumatism 36, 1087-1097.
31. Suenaga, R., Mitamura, K., Evans, M.J. and Abdou, N.I. (1996) Binding affinity and quantity of estrogen receptor in peripheral blood monocytes ofpatients with systemic lupus erythematosus. Lupus 5, 227-231.
32. Cohen, J.H., Danel, L., Cordier, G. et al. (1983) Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8 positive cells. Journal of Immunology 131, 2767-2771.
33. Weusten, J.J.A.M., Blankenstein, M.A. and Gmelig Meyling et al. 1986 Presence of oestrogen receptors in human blood mononuclear cells and thymocytes. Acta Endocrinologica 112 409-414.
34. Suenaga, R., Evans, M.J., Mitamura, K. and Abdou, N.I. (1998) Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. Journal of Rheumatology 25, 1305-1312.
35. Kassi, E.N., Vlachoyiannopoulos, P.G., Moutsopoulos, H.M. et al. (2001) Molecular analysis of estrogen receptor alpha and beta in lupus patients. European Journal of Clinical Investigation 31, 86-93.
36. Suenaga, R., Rider, V., Evans, M.J. and Abdou, N.I. (2001) In vitro-activated human lupus T cells express normal estrogen receptor proteins which bind to the estrogen response element. Lupus 10, 116-122.
37. Kassi, E., Vlachoyiannopoulos, P.G., Kominakis, A. et al. (2005) Estrogen receptor alpha gene polymorphism and systemic lupus erythematosus: a possible risk? Lupus 14, 391-398.
38. Johansson, M., Arlestig, L., Moller, B. etal. (2005) Oestrogen receptor a gene polymorphisms in systemic lupus erythematosus. Annals of Rheumatic Disease 64, 1611-1617.
39. Zhao, C., Dahlman-Wright, K. and Gustafsson, J.-A. (2008) Estrogen receptor ß: an overview and update. Nuclear Receptor Signaling 6, 1-10.
40. Jakacka, M., Ito, M., Weiss, J. et al. (2001) Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway. Journal of Biological Chemistry 276, 13613-13621.
41. Lahita, R.G. (2000) Sex hormones and systemic lupus erythematosus. Rheumatic Disease Clinics of North America 26, 951-968.
42. Lahita, R.G., Bradlow, H.L., Kunkel, H.G. and Fishman, J. (1981) Increased 16 alpha hydroxyl-ation of estradiol in systemic lupus erythematosus. Journal of Clinical Endocrinology and Metabolism 53, 174-178.
43. Namjou, B., Kilpatrick, J. and Harley, J.B. (2007) Genetics of clinical expression in SLE. Autoimmunity 40, 602-612.
44. Rhodes, B. and Vyse, T.J. (2007) General aspects of the genetics of SLE. Autoimmunity 40, 550-559.
45. Simard, L. and Costenbader, K.H. (2007) What can epidemiology tell us about systemic lupus erythematosus? International Journal of Clinical Practice 61, 1170-1180.
46. Deapen, D., Escalante, A., Weinrib, L. etal. (1992) A revised estimates of twin concordance in systemic lupus erythematosus. Arthritis and Rheumatism 35, 311-318.
47. Tenbrock, K., Juang, Y.-T., Kyttaris, V.C. and Tsokos, G.C. (2007) Altered signal transduction in SLE T cells. Rheumatology 46, 1525-1530.
48. Bauer, J.W., Baechler, E.C., Petri, M. etal. (2006) Elevated serum levels ofinterferon-regulated chemokines are biomarker for active human systemic lupus erythematosus. PLoS Med. 3, 2274-2284.
49. Fontenot, J.D., Gavin, M.A. and Rudensky, A.Y. (2003) Foxp3 programs the development and function of CD4 + CD25-regulatory T cells. Nature Immunology 4, 330-336.
50. Marson, A., Kretschmer, K. and Frampton, G.M. et al. (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931-935.
51. Schubert, L.A., Jeffery, E., Zhang, Y. et al. (2001) Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. Journal of Biological Chemistry 276, 37672-37679.
52. Valencia, X., Yarboro, C., Illei, G. and Lipsky, P.E. (2007) Deficient CD4 + CD25high T regulatory cell function in patients with active systemic lupus erythematosus. Journal of Immunology 178, 2579-2588.
53. Polanczyk, M.J., Hopke, C. and Huan, J. et al. (2005) Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. Journal of Neuroimmunology 170, 85-92.
54. Tai, P., Wang, J., Jin, H. et al. (2008) Induction of regulatory T cells by physiological level estrogen. Journal of Cell Physiology 214, 456-464.
55. Floess, S., Freyer, J., Siewert, C. et al. (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5, 0169-0178.
56. Turner, B.M. (2000) Histone acetylation and an epigenetic code. BioEssays 22, 836-845.
57. Jenuwein, T. and Allis, D.C. (2001) Translating the histone code. Science 293, 1074-1080.
58. Leader, J.E., Wang, C., Fu, M. and Pestell, R.G. (2006) Epigenetic regulation of nuclear steroid receptors. Biochemical Pharmacology 72, 1589-1596.
59. Leader, J.E., Wang, C., Popov, V.M. etal. (2006) Epigenetics and the estrogen receptor. Annals of the New York Academy of Sciences 1089, 73-87.
60. O'Malley, B.W. (2007) Coregulators: from whence came these "master genes". Molecular Endocrinology 21, 1009-1013.
61. Saha, A., Wittmeyer, J. and Cairns, B.R. (2006) Chromatin remodelling: the industrial revolution of DNA around histones. Nature Reviews Molecular Cell Biology 7, 437-447.
62. Metivier, R., Reid, G. and Gannon, F. (2006) Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. European Molecular Biology Organization Reports 7, 161-167.
63. Rosenfeld, M.G., Lunyak, V.V. and Glass, C.K. (2006) Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcription response. Genes and Development 20, 405-428.
64. Shang, Y., Hu, X., DiRenzo, J. et al. (2000) Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852.
65. Carroll, J.S. and Brown, M. (2006) Estrogen receptor target gene: an evolving concept. Molecular Endocrinology 10, 1707-1714.
66. Kininis, M., Chen, B.S., Diehl, A.G. et al. (2007) Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Molecular and Cellular Biology 27, 5090-5104.
67. Carroll, J.S., Liu, S.X., Brodsky, A.S. et al. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43.
68. Carroll, J.S., Meyer, C.A., Song, J. et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nature Genetics 38, 1289-1297.
69. Lonard, D.M. and O'Malley, B.W. (2006) The expanding cosmos of nuclear receptor coacti-vators. Cell 125, 411-414.
70. Kishimoto, M., Fujiki, R., Takezawa, S. etal. (2006) Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocrine Journal 53, 157-172.
71. Heinzel, T., Lavinsky, R.M., Mullen, T.M. etal. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387, 43-48.
72. Nagy, L., Kao, H.Y., Chakravarti, D. et al. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380.
73. Goodman, R.H. and Smolik, S. (2002) CBP/p300 in cell growth, transformation, and development. Genes and Development 14, 1553-1577.
74. Baek, S.H., Ohgi, K.A., Rose, D.W. et al. (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110, 55-67.
75. Gamble, M.J. and Kraus, W.L. (2007) Visualizing the histone code on LSD1. Cell 128, 433-434.
76. Garcia-Bassets, I., Kwon, Y.-S., Telese, F. etal. (2007) Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128, 505-518.
77. Zwijsen, R.M.L., Buckel, R.S., Hijmans, E.M. et al. (1998) Ligand-independent recruitment of steroid receptor coactivators to the estrogen receptor by cyclin D1. Genes and Development 12, 3488-3498.
78. Wang, C., Fan, S., Li, Z. et al. (2005) Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Research 65, 6557-6567.
79. Crispin, J.C., Kyttaris, V.C., Juang, Y.T. and Tsokos, G.C. (2008) How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends in Immunology 29, 110-115.
80. Feinberg, A.P. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433-440.
81. Gosden, R.G. and Feinberg, A.P. (2007) Genetics and epigenetics-Nature's pen-and-pencil set. New England Journal of Medicine 356, 731-733.
82. Johnson, A.B. and Barton, M.C. (2007) Hypoxia-induced and stress-specific changes in chromatin structure and function. Mutation Research 618, 149-162.
83. Stearns, V., Zhou, Z. and Davidson, N.E. (2007) Epigenetic regulation as a new target for breast cancer therapy. Cancer Investigation 25, 659-665.
84. Sharma, D., Blum, J., Yang, X. et al. (2005) Release of methyl CpG binding proteins and histone deacetylase 1 from the estrogen receptor a (ER) promoter upon reactivation in ER-negative human breast cancer cells. Molecular Endocrinology 19, 1740-1751.
85. Richardson, B., Scheinbart, L., Strahler, J. et al. (1990) Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis and Rheumatism 33, 1665-1673.
86. Inui, A., Ogasawara, H., Naito, T. et al. (2007) Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clinical Rheumatology 26, 1675-1678.
87. Dhasarathy, A., Kajita, M. and Wade, P.A. (2007) The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Molecular Endocrinology 21, 2907-2918.
88. Kriegel, M.A., Li, M.O., Sanjabi, S. et al. (2006) Transforming growth factor-beta: recent advances on its role in immune tolerance. Current Rheumatology Reports 8, 138-144.
89. Nawaz, Z. and O'Malley, B.W. (2004) Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Molecular Endocrinology 18, 493-499.
90. Baker, S.P. and Grant, P.A. (2005) The proteasome: not just degrading anymore. Cell 123, 361-363.
91. Zhang, H., Sun, L., Liang, J. et al. (2006) The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. European Molecular Biology Organization Journal 25, 4223-4233.
92. Zhao, C., Matthews, J., Tujague, M. et al. (2007) Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor a in human breast cancer cells. Cancer Research 67, 3955-3962.
93. Boonyaratanakornkit, V. and Edwards, D.P. (2007) Receptor mechanisms mediating non-genomic actions of sex steroids. Seminars in Reproductive Medicine 25, 139-153.
94. Watanabe, M., Yanagisawa, J., Kitagawa, H. et al. (2001) A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. European Molecular Biology Organization Journal 20, 1342-1352.
95. Ko, L., Cardona, G.R., Henrion-Caude, A. and Chin, W.W. (2002) Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors. Molecular and Cellular Biology 22, 357-369.
96. Kammer, G.M., Laxminarayana, D. and Khan, I.U. (2004) Mechanisms of deficient type I protein kinase A activity in lupus T lymphocytes. International Reviews of Immunology 23, 225-244.
97. Gorjestani, S., Rider, V., Kimler, B.F. et al. (2008) Extracellular signal regulated Kinase 1/2 signaling in SLE T cells is influenced by estrogen and disease activity. Lupus 17, 548-554.
98. Rao, T. and Richardson, B. (1999) Environmentally induced autoimmune disease: potential mechanisms. Environmental Health Perspective 107, 737-742.
99. Molina, V. and Shoenfeld, Y. (2005) Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38, 235-245.
100. Inadera, H. (2006) The immune system as a target for environmental chemicals: xenoestrogens and other compounds. Toxicology Letters 164, 191-206.
101. Lascombe, I., Beffa, D., Ruegg, U. etal. (2000) Estrogenic activity assessment of environmental chemicals using in vitro assays: identification of two new estrogen compounds. Environmental Health Perspectives 108, 621-629.
102. Yurino, H., Ishikawa, S., Sato, T. etal. (2004) Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicological Sciences 81, 139-147.
103. Sobel, E.S., Wang, F., Butfiloski, E. et al. (2005) Comparison of chlordecone effects on autoimmunity in (NZB/NZW) F(1) and BALB/c mice. Toxicology 218, 81-90.
104. 1 mice. Toxicological Sciences 99, 141-152.
105. Yung, R.L., Johnson, K.J. and Richardson, B.C. (1995) A new concept in the pathogenesis of drug-induced lupus. Laboratory Investigation 73, 746-759.
106. Carroll, D.G. and Cavanagh, L.E. (2007) Drug-induced lupus associated with synthetic conjugated estrogens. Annals of Pharmacotherapy 41, 702-705.
107. Feinberg, A.P. (2008) Epigenetics at the epicenter of modern medicine. Journal of the American MedicalAssociation 299, 1345-1350.
108. Torres-Padilla, M.E. (2008) Cell identity in the preimplantation mammalian embryo: an epigenetic perspective from the mouse. Human Reproduction 23, 1246-1252.